Introduction
============

The World Health Organization (WHO) defines infertility as the inability to conceive a child after 1 year of regular, unprotected intercourse. Infertility currently affects approximately 15% of all couples, with an increase anticipated over the next 20 years. Approximately 50% of cases of infertility can be attributed to male factors \[[@B1]\]. The defects causing male infertility can be classified as related to the hypothalamus or pituitary gland, the testicles, or defective sperm delivery due to disorders in the penis or related sexual glands \[[@B2]\].

Azoospermia and abnormal semen parameters, such as a decrease in sperm count, are often observed in infertile men. Azoospermia can be classified as obstructive azoospermia (OA) or non-obstructive azoospermia (NOA). The causes of OA can be further divided into congenital and acquired closure of the ejaculatory tract, which can occur anywhere along the spermatic cord and epididymis. The most common cause of OA is vasectomy \[[@B3]\]. However, it may also be caused by the epididymis, vas deferens, or ejaculatory duct pathology relating to genitourinary infection, iatrogenic injury during scrotal or inguinal surgical procedures, and congenital anomalies such as congenital bilateral agenesis of the vas deferens (CBAVD) \[[@B4]\]. NOA is caused by disorders related to sperm formation in the testicles and can be classified into hypospermatogenesis (HP), maturation arrest (MA), and Sertoli cell-only syndrome (SCO) according to the cell composition of the seminiferous tubules.

Although there are many causes of male infertility, researchers in Korea have not clearly analyzed the prevalence of each cause of male infertility. The aim of this study is to investigates the various causes of male infertility and attempts to take multiple approaches in examining the causes of infertility in males.

Methods
=======

This study included a total of 920 male patients with infertility who visited Cheil General Hospital between January 1st and December 31th 2009 and were cared for by a single physician. This study was a retrospective study using data from medical records. After an evaluation of the subjects\' medical history, the subjects\' physical condition and semen were also examined. A Prader orchidometer was used during the physical exam to measure testicular volume and Dubin and Amelar\'s method was used to verify the existence of a varicocele \[[@B5]\].

Semen analysis was performed after the patients had abstained from sexual intercourse for 3 to 5 days. Based on the WHO definition (4th ed. 1999), the semen was classified into 3 categories: normal range, abnormal range, or azoospermia. Patients diagnosed with azoospermia then underwent serum hormone tests, including testosterone, FSH, LH, chromosomal analysis with azoospermic factor microdeletion and a testicular biopsy. NOA was defined as the condition in which the testicular tissue test identified a sperm formation defect, without evidence of closure of the ejaculatory duct. The testicular tissue was classified into HP, MA, and SCO according to the cell composition of the seminiferous tubules. Subjects who had features of both MA and SCO were diagnosed with MA. OA was defined by normal spermatogenesis by testicular biopsy. A chromosomal analysis was performed to search for genetic abnormalities that might account for the azoospermia.

Results
=======

The average age of patients was 35.3±8.7. Among the 920 patients who visited the hospital for male infertility between January 1 and December 31, 2009, semen analysis revealed 555 patients (60.3%) within the normal range, 269 patients (29.2%), within the abnormal range, and 96 (10.5%) with azoospermia.

Varicoceles were diagnosed in 84 out of 555 normal-range patients (15.1%) and in 113 out of the 269 abnormal-range patients (42.0%) ([Table 1](#T1){ref-type="table"}). Among the 96 patients who were diagnosed with azoospermia, 24 patients (25%) were diagnosed with OA, 68 patients (71%) were diagnosed with NOA, and the remaining 4 azoospermia patients (4%) were found to have retrograde ejaculation. Among the 24 OA patients, 12 patients had obstruction of the vas deferens or epididymis, 10 showed CBAVD, and 2 patients were diagnosed with ejaculatory duct obstruction. Among the 68 NOA patients, 33 were diagnosed with SCO, 10 with MA, 8 with HP, and 17 showed chromosomal abnormalities. Forty-seven patients had chromosomal abnormalities: 47,XXY in 14 patients: 46,XX in 1 patient: and Y chromosome microdeletions in 2 patients ([Figure 1](#F1){ref-type="fig"}).

Discussion
==========

Male infertility is caused by various factors, such as disorders of the endocrine system, disturbances in ejaculation, bacterial or viral infection, immunologic factors, varicoceles, undescended testis and anabolic steroid use. However, a clear etiology cannot be determined for many cases of male infertility. Excluding patients who have previously had a vasectomy, nearly 10% to 15% of men have azoospermia, a condition in which semen is produced but does not contain sperm \[[@B6]\].

In this study, 60.3% had a normal range of semen parameters, 29.2% had an abnormal range of semen parameters and 10.5% had azoospermia. Azoospermia can be classified into OA, a condition in which the sperm passage is congenitally or gradually closed, and NOA, in which there is disordered formation of sperm within the testicles. Another type of azoospermia is caused by disordered ejaculation. Forty percent of azoospermic cases are caused by post-testicular obstruction. Surgical treatment such as vasovasostomy or vasoepididymostomy should be considered for OA \[[@B7]-[@B10]\].

ICSI is a procedure that uses micromanipulation, which is commonly used during IVF. ICSI requires only one living sperm to achieve fertilization of one egg. It was demonstrated that this approach is superior to subzonal insemination after the first four human pregnancies by ICSI were reported by Palermo et al. \[[@B11]\]. This procedure presented a relatively high pregnancy success rate and opened a new era for treating infertility \[[@B11]\]. In the past, due to a lack of accreditation, ICSI was only implemented if regular external fertilization could not be achieved. This was often because the number of motile sperm in each ejaculated sperm was below 500,000 and the ratio of normal sperm was below 4%. However, ICSI is now also being used in the following cases: 1) sperm count \<2×10^6^ sperm/mL; 2) sperm motility \<5%; 3) normal morphology \<4% by strict criteria; 4) use of microsurgical epididymal sperm aspiration (MESA) or testicular sperm extraction (TESE) to acquire sperm, and 5) NOA such as MA and SCO \[[@B12]-[@B14]\].

Since treatment for azoospermia differs according to etiology, male patients with azoospermia should receive treatment based on accurate diagnosis and classification. This should lead to a high pregnancy success rate. According to previously reported data, 31% of azoospermia is caused by obstructive factors, 54% is caused by non-obstructive factors generated by disorders in testicular function, and the remaining 15% appear normal without evidence of obstruction \[[@B15]\]. Among the 96 patients that were diagnosed with azoospermia in this study, 24 were OA patients (25%), 68 were NOA (71%), and the remaining 4 azoospermia patients (4%) demonstrated retrograde ejaculation.

In treating CBAVD or OA, which cannot be treated surgically, successful fertilization and pregnancy can be achieved through MESA and ICSI \[[@B16]\]. Furthermore, if it is impossible to extract the sperm through MESA due to obstruction, hypoplasia or surgical removal of epididymis, TESE and ICSI can be used instead to achieve sperm extraction \[[@B17]\]. Of those patients with NOA, 60% achieve pregnancy using ICSI after extracting a small amount of sperm through testicular biopsy. There are no treatment options for the remaining 40% even if multiple testicular sperm extraction operation were performed.

Varicocele is one of the most common causes of male factor infertility in patients that visit the hospital for infertility. Occurring in nearly 15% of male adults, varicocele is also found in 30% to 35% of primary infertility and 69% to 81% of secondary infertility \[[@B18],[@B19]\]. Similar results about varicocele patients were observed in our study. Abnormal semen parameters in infertility patients with varicocele were first reported in 1965. At the same time, a connection between varicoceles and reduced sperm count and motility, testicular size and histological changes were also proposed \[[@B20]\].

In 1992, the WHO confirmed the correlation between varicoceles and reduced testicular volume, poor sperm quality and reduced Leydig cell function. Furthermore, several studies conducted on animal models and humans reported that varicoceles gradually trigger testicular damage depending on the length of disease \[[@B19],[@B21],[@B22]\].

Studies that have previously been carried out abroad have reported that the percent of varicoceles among patients with male infertility is 42.2% \[[@B23]\]. Varicoceles were diagnosed in 84 out of 555 infertility patients (15.1%) who presented with semen analysis in the normal range and 113 out of 269 infertility patients (42.0%) whose semen was in the abnormal range. When compared with the results of previous studies, the results of this study presented a similar percent of varicoceles causing abnormal semen analysis results.

Various causes of male infertility have been reported and diverse treatment methods can be adopted for each cause. In this study, the most common cause of male infertility was idiopathic. However, other causes of male infertility are also important to consider. In this regard, research must be conducted on a larger number of patients to accurately assess the various causes of infertility in Korean patients and to investigate various infertility treatment methods.
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